Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT00483457
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of a malignancy for which therapy on or off a clinical trial with an inhibitor of the EGFR pathway is under consideration
* The therapy under consideration may be monotherapy or combined with other therapies as long as other therapies do not typically cause a rash
PATIENT CHARACTERISTICS:
* INR ≤ 3.0 (for patients receiving concurrent warfarin)
* No severe underlying skin disorder (e.g., toxic epidermal necrolysis or severe dermatitis) that would preclude study treatment
* No bleeding diatheses that would preclude safe biopsy
* No allergy to lidocaine or similar local anesthetics
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00483457
Study Brief:
Protocol Section:
NCT00483457